Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

Clinical trial NCT00002952 · COMPLETED

Trial details

NCT number: NCT00002952
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1997-01-01
Primary completion: 2002-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.